Humanitarian Emergencies Represent Extraordinary Challenges for Blood Delivery

The availability of blood products, as well as ensuring the safety of blood transfusion, is often a significant concern in times of humanitarian emergencies. During the Monday morning session, “Availability and Safety of Blood Transfusion in Humanitarian Emergencies,” three speakers – Christopher Gresens, MD; Yetmgeta E. Abdella, MD, MPH; and Cees Smit Siblinga, MD, PhD, … Continue reading “Humanitarian Emergencies Represent Extraordinary Challenges for Blood Delivery”

Missed the Plenary Scientific Oral Abstracts? Here’s a Quick Rundown

Iron status in diverse donor population Data from the Red Blood Cell-Omics (RBC-Omics) study suggest that African American and Asian blood donors may be less likely to have lower levels of iron stores compared with non-Hispanic white donors, while Hispanic donors appear to have a greater risk for low iron, lead author lead author Bryan … Continue reading “Missed the Plenary Scientific Oral Abstracts? Here’s a Quick Rundown”

How Can Your Blood Center Best Serve Transgender Donors?

It may not be a question to which you’ve given a lot of thought, especially if you work in a small or rural blood center. But since a 2015 FDA guidance allowing male or female gender to be self-identified and self-reported went into effect, many blood centers are seeing an increase in the number and … Continue reading “How Can Your Blood Center Best Serve Transgender Donors?”

INFORM: No Difference in Mortality Seen with Exposure to “Oldest” Old Blood vs. Freshest

More evidence for the safety of older RBCs comes from a pre-specified exploratory analysis of data from the nearly 25,000-patient INFORM trial. The researchers found no significant difference in in-hospital mortality (hazard ratio, 0.92) between patients given blood with a median age of 36-42 days old versus those receiving median-aged blood of 7 days or … Continue reading “INFORM: No Difference in Mortality Seen with Exposure to “Oldest” Old Blood vs. Freshest”

Hemphill-Jordan Leadership Award Recipient Discusses Blood Safety Policies

During his Annual Meeting lecture, Brian Custer, MPH, PhD, Associate Director at Blood Systems Research Institute, talked about blood safety policies and how experts develop evidence to help decision makers. He focused on both epidemiological data and health economics data. According to Dr. Custer, the former has been a foundation for policy decision-making, remaining key … Continue reading “Hemphill-Jordan Leadership Award Recipient Discusses Blood Safety Policies”

Insights from Ortho Clinical Diagnostics Industry Workshop, “Standardization and Validation of Titrations in Perinatal Clinical Situations”

Hemolytic disease of the fetus and newborn (HDFN), often called erythroblastosis fetalis, is a blood disorder that occurs when a mother’s blood type is incompatible with that of her unborn child. Titration studies are an aspect of the standard of care for perinatal evaluation of patients who have become alloimmunized with an antibody of potential … Continue reading “Insights from Ortho Clinical Diagnostics Industry Workshop, “Standardization and Validation of Titrations in Perinatal Clinical Situations””

Armed Services Blood Program/AABB Workshop Highlights Program’s Critical Missions

The Armed Services Blood Program/AABB Workshop was held Sunday afternoon, offering attendees a close look at the objectives and activities of the US military blood program’s operations. Held every year at the AABB Annual Meeting, the always popular session once again featured an overview of the Armed Services Blood Program’s initiatives and research projects, as … Continue reading “Armed Services Blood Program/AABB Workshop Highlights Program’s Critical Missions”

Martin Olsson Receives Tibor Greenwalt Memorial Award

Martin Olsson received the 2017 Tibor Greenwalt Memorial Award for outstanding achievements in molecular genetics of red-cell surface antigens.

Martin Olsson received the 2017 Tibor Greenwalt Memorial Award for outstanding achievements in molecular genetics of red-cell surface antigens.

Hello Arbovirus, My Old Friend

Arboviruses, such as Zika virus (ZIKV), have threatened, and will continue to threaten, the safety of the blood supply. This was the key takeaway from Sunday’s “TTD I: What Emerging Infectious Disease Agents Concern Us Today – Focus on ZIKV.” The session offered an update on ZIKV, focusing on local and international responses, the evolution … Continue reading “Hello Arbovirus, My Old Friend”

Utilizing Personalized and Precision Medicine to Solve Medical Mysteries

Patients with rare blood types, multiple antibodies or antibodies to high prevalence antigens present health care providers can often present treatment challenges. In the Sunday session “Personalized and Precision Medicine Converge to Meet Rare Blood Needs,” a team of speakers outlined medical mysteries solved with the help of personalized and precision medicine. David Friedman, MD; … Continue reading “Utilizing Personalized and Precision Medicine to Solve Medical Mysteries”